Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.

Key developments of interest over the last month include: the UK government's communications in connection with the Chancellor's annual Mansion ...